TABLE 3.
Regression Variable | Effect Estimate (mL) | se (95% CIs) | p |
---|---|---|---|
Unadjusted analysis | |||
Study observation day | +297 | 32 (+234 to +360) | <0.001 |
Clinician-recognized ARDS | +525 | 536 (–525 to +1,574) | 0.33 |
Adjusted analysis | |||
Study observation day | +297 | 32 (+234 to +360) | <0.001 |
Presence of shock at admission | +2,133 | 559 (+1,053 to +3,229) | <0.001 |
Oxygenation impairmenta | +424 | 359 (–279 to +1,128) | 0.24 |
Presence of congestive heart failure or chronic kidney disease | –1,010 | 652 (–2,289 to +268) | 0.12 |
Clinician-recognized ARDS | –781 | 543 (–1,846 to +283) | 0.15 |
ARDS = acute respiratory distress syndrome.
aOxygenation impairment was categorized into four ordinal groups using the lowest Pao2:Fio2 and/or Spo2:Fio2 ratio during the first 4 ICU days: severe ARDS (Pao2:Fio2 ≤ 100), moderate ARDS (Pao2:Fio2 ≥ 101 and ≤ 200), mild ARDS (Pao2:Fio2 ≥ 201 and ≤ 300), or ARDS met by Spo2:Fio2 criteria only (lowest Pao2:Fio2 > 300, but lowest Spo2:Fio2 ≤ 315 while Spo2 > 96%) (29).